| Product Code: ETC9949302 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Multi-omics Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Multi-omics Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Multi-omics Market - Industry Life Cycle |
3.4 United Kingdom (UK) Multi-omics Market - Porter's Five Forces |
3.5 United Kingdom (UK) Multi-omics Market Revenues & Volume Share, By Products & Services, 2021 & 2031F |
3.6 United Kingdom (UK) Multi-omics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 United Kingdom (UK) Multi-omics Market Revenues & Volume Share, By Platform, 2021 & 2031F |
3.8 United Kingdom (UK) Multi-omics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 United Kingdom (UK) Multi-omics Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 United Kingdom (UK) Multi-omics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and precision healthcare in the UK |
4.2.2 Rising prevalence of chronic diseases driving the adoption of multi-omics technologies |
4.2.3 Government initiatives and funding to support research and development in the field of multi-omics |
4.3 Market Restraints |
4.3.1 High initial costs associated with multi-omics technologies and services |
4.3.2 Lack of standardized protocols and regulations for multi-omics data analysis |
4.3.3 Limited awareness and understanding of multi-omics technologies among healthcare professionals and patients in the UK |
5 United Kingdom (UK) Multi-omics Market Trends |
6 United Kingdom (UK) Multi-omics Market, By Types |
6.1 United Kingdom (UK) Multi-omics Market, By Products & Services |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Multi-omics Market Revenues & Volume, By Products & Services, 2021- 2031F |
6.1.3 United Kingdom (UK) Multi-omics Market Revenues & Volume, By Instruments, 2021- 2031F |
6.1.4 United Kingdom (UK) Multi-omics Market Revenues & Volume, By Consumables, 2021- 2031F |
6.2 United Kingdom (UK) Multi-omics Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Multi-omics Market Revenues & Volume, By Single-cell, 2021- 2031F |
6.2.3 United Kingdom (UK) Multi-omics Market Revenues & Volume, By Bulk, 2021- 2031F |
6.3 United Kingdom (UK) Multi-omics Market, By Platform |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Multi-omics Market Revenues & Volume, By Genomics, 2021- 2031F |
6.4 United Kingdom (UK) Multi-omics Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Multi-omics Market Revenues & Volume, By Cell Biology, 2021- 2031F |
6.5 United Kingdom (UK) Multi-omics Market, By End use |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Multi-omics Market Revenues & Volume, By Academic & Research Organizations, 2021- 2031F |
7 United Kingdom (UK) Multi-omics Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Multi-omics Market Export to Major Countries |
7.2 United Kingdom (UK) Multi-omics Market Imports from Major Countries |
8 United Kingdom (UK) Multi-omics Market Key Performance Indicators |
8.1 Adoption rate of multi-omics technologies in healthcare institutions |
8.2 Number of research grants and funding allocated for multi-omics projects in the UK |
8.3 Integration of multi-omics data with electronic health records (EHR) systems in the UK |
9 United Kingdom (UK) Multi-omics Market - Opportunity Assessment |
9.1 United Kingdom (UK) Multi-omics Market Opportunity Assessment, By Products & Services, 2021 & 2031F |
9.2 United Kingdom (UK) Multi-omics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 United Kingdom (UK) Multi-omics Market Opportunity Assessment, By Platform, 2021 & 2031F |
9.4 United Kingdom (UK) Multi-omics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 United Kingdom (UK) Multi-omics Market Opportunity Assessment, By End use, 2021 & 2031F |
10 United Kingdom (UK) Multi-omics Market - Competitive Landscape |
10.1 United Kingdom (UK) Multi-omics Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Multi-omics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here